Patient Characteristics
This study involved 42,476 admissions of 40,345 unique patients from 12 units, which corresponded to 362,805 HD at the nursing units across both groups. There were 2,131 patients who were admitted to an intervention and a control unit at different times (5.02% of all admissions). The patient characteristics differed significantly between the two groups (Table 1). The control units were characterized by older patients, a longer stay, fewer female patients, and more patients with a fall history at admission, comorbidity status, and surgical procedures. Regarding the primary diagnosis, about half of the patients in the intervention group had a respiratory or digestive disease or any form of cancer, while control patients had a greater diversity of diagnoses. The significant patient characteristics were used to control the patient-level differences for the group effect on the fall rate.
Table 1. Characteristics of patients in the intervention and control groups
Variable
|
Intervention
(n = 24,336)
|
Control
(n = 18,140)
|
P
|
|
Age, years
|
61.45 (61.23 to 61.67)
|
65.30 (65.05 to 65.54)
|
< .001
|
|
Length of stay, days
|
7.96 (7.91 to 8.00)
|
9.25 (9.13 to 9.37)
|
< .001
|
|
Sex, female
|
12,512 (51.41)
|
9,053 (49.91)
|
.002
|
|
Presence of fall history at admission
|
2,873 (11.88)
|
4,138 (23.58)
|
< .001
|
|
Presence of secondary diagnoses
|
10,641 (43.73)
|
9,361 (51.60)
|
< .001
|
|
Presence of surgical procedures
|
2,483 (10.20)
|
8,575 (47.27)
|
< .001
|
|
Primary medical diagnosis
|
< .001
|
|
|
Respiratory or digestive disease
|
6,150 (25.21)
|
3,472 (19.14)
|
|
|
Cancer
|
5,990 (24.61)
|
2,382 (13.13)
|
|
|
|
Symptom or injury
|
2,784 (11.44)
|
2,561 (14.12)
|
|
|
Cardiovascular disease
|
995 (4.09)
|
3,096 (17.07)
|
|
|
Benign tumor
|
860 (3.53)
|
211 (1.16)
|
|
|
Infectious disease
|
514 (2.11)
|
388 (2.14)
|
|
|
Neurologic disease
|
182 (0.75)
|
597 (3.29)
|
|
|
Other†
|
6,861 (28.19)
|
5,433 (29.95)
|
|
|
|
|
|
|
|
|
|
|
|
Data are n (%) or mean (95% confidence interval) values.
† Including genitourinary, musculoskeletal, eye, ear, and skin diseases.
Comparison of Primary Outcomes
There were 325 fall events in the intervention group and 382 in the control group. The mean fall rate decreased from 1.92 to 1.79 in the intervention group and increased from 1.95 to 2.11 in the control group. Simple t-test comparisons of monthly rates revealed that the fall rate was lower in the intervention group (1.79 vs. 2.11, t = 2.13, P = .038). The longitudinal analysis of nursing-unit-level data showed no autocorrelation within groups (P = .403), while the group effect was significant for the fall rate (z = –2.10, P = .036). The fixed-effect model also predicted a significant group effect (t = 2.13, P = .038). The CITS analysis revealed 29.73% reduction of significant decrease in the fall rate after introducing the intervention (Rate ratio [RR] = −0.30, P = .039), followed by a nonsignificant long term effect compared with the underlying time trend (RR= 0.01, P = .059) (Table 2). In the control group, there was 16.58% reduction which was no significant change in the fall rate either immediately (RR = − 0.17, P = .200) or over time (RR = −0.01, P = .057).
Table 2. Results of controlled interrupted time-series analysis of fall rates
Group
|
Rate of change prior to IN@SIGHT
|
Change in level after introducing IN@SIGHT
|
Change in slop after introducing IN@SIGHT
|
Intervention
|
−0.07
(−0.22 to 0.08)
|
−0.30
(−0.58 to –0.14)*
|
0.01
(<−0.01 to 0.02)
|
Control
|
0.08
(−0.07 to 0.22)
|
−0.17
(−0.42 to 0.09)
|
0.01
(<−0.01 to 0.02)
|
Data are rate ratio (95% confidence interval) values, * P < .05
Secondary Outcomes: Injury Rates and Process Indicators
During the intervention period there was no significant intergroup difference in the mean injury rate (0.42 vs. 0.31, t = − 1.54, P = .131). There was also no significance found in the GLS analysis (z = 1.69, P = .091) or fixed-effect model (t = 1.65, P = .105).
Both the fall risk and injury risk factors were assessed within 24 hours of hospital admission in all patients in the intervention group, while no such data were available for about 75% HD in the control group (Table 3). Universal precautions and education for at-risk HD were provided to most patients in the control group. The communication practices and environmental interventions were better in the control group by 18 months, at which time those in the intervention group had reached the same level. While the rate of risk-targeted interventions increased incrementally in both groups, the intervention group showed better adherence than the control group at the 4th period (29.5% vs. 18.1%, P < .001).
Table 3. Changes in process indicators in the two groups over time
Item
|
Baseline
(1 month)
|
Postintervention period
|
|
First
6 months
|
Second
6 months
|
Third
6 months
|
Fourth
6 months
|
|
Int. vs. Cnt.
|
Int. vs. Cnt.
|
Int. vs. Cnt.
|
Int. vs. Cnt.
|
Int. vs. Cnt.
|
Basis
|
Hospital days (HD)
|
8,254, 4,207
|
45,133, 31,675
|
46,403, 39,733
|
44,418, 44,741
|
42,553, 43,161
|
Days on which no risk assessment performed, %
|
72.5, 73.4 ns
|
0, 72.6**
|
0, 77.1**
|
0, 71.7**
|
0, 79.8**
|
At-risk days relative to HD, %
|
43.0, 42.1 ns
|
24.5, 43.5**
|
31.4, 38.6**
|
32.7, 42.9**
|
34.6, 41.5**
|
Outcome
Indicators
|
Rate of falls
|
2.46, 2.76ns
|
1.78, 1.81ns
|
1.38, 2.23**
|
2.17, 2.27ns
|
1.80, 2.15ns
|
Rate of tall-related injuries
|
NA
|
0.52, 0.24*
|
0.22, 0.22ns
|
0.52, 0.52ns
|
0.41, 0.30ns
|
Process indicators
|
Patients assessed using a fall-risk tool within 24 hours of hospital admission, %
|
99.3, 98.6 ns
|
100.0‡ , 99.2**
|
100.0‡, 70.8**
|
100.0‡, 95.3**
|
100.0‡, 98.8**
|
Patients assessed for injury risk factors (ABCs †) within 24 hours of hospital admission, %
|
0, 0 ns
|
100.0‡ , 0**
|
100.0‡, 0**
|
100.0‡, 0**
|
100.0‡, 0**
|
At-risk patients to which universal precautions were applied within 24 hours of risk identification, %
|
86.1§, 100.0 §**
|
69.7§, 78.9 §**
|
88.8§, 99.9 §**
|
37.8, 99.9**
|
91.2, 99.9**
|
At-risk patients who received education interventions within 24 hours of risk identification, %
|
33.1, 98.1**
|
79.6, 97.8**
|
At-risk patients who received risk-targeted interventions within 24 hours of risk identification, %
|
<0.01, <0.01 ns
|
<0.01, <0.01 ns
|
<0.01, <0.01 ns
|
12.5, 13.3 ns
|
29.5, 18.1**
|
At-risk patients who received communication interventions within 24 hours of risk identification, %
|
61.7 §, 79.4 §**
|
87.6 §, 99.9 §**
|
76.0 §, 81.1 §**
|
30.2, 38.7**
|
66.2, 66.7 ns
|
At-risk patients who received environmental interventions within 24 hours of risk identification, %
|
39.5, 54.9**
|
76.7, 76.0 ns
|
|
|
|
|
|
|
|
|
|
|
|
Int., intervention group; Cnt., control group; NA, not applicable
† Age, bone health, anticoagulants, and current surgery
‡ Function that was performed automatically by the analytic tool for predicting the fall risk
§ Data collection not categorized in detail
ns Not significant, * P < .05, ** P < .001
In the patient-level analysis adjusted for patient characteristics, the overall group effect was significant (Odds ratio [OR] = 0.52, 95% CI = 0.42 to 0.65, P < .001). After 6 months, the group effect occurred in the second (OR = 0.25, 95% CI = 0.12 to 0.53, P < .001) and the third periods (OR = 0.36, 95% CI = 0.21 to 0.61, P < .001).
Table 4. Results of patient-level logistic regression over time
Variable
|
Postintervention period
|
|
First
6 months (n = 10,514)
|
Second
6 months (n = 9,849)
|
Third
6 months (n = 11,196)
|
Fourth
6 months (n = 10,815)
|
|
Group of intervention
|
0.66
(0.44 to 1.00)
|
0.25 **
(0.12 to 0.53)
|
0.36 **
(0.21 to 0.61)
|
1.07
(0.82 to 1.59)
|
|
Age
|
1.06 **
(1.04 to 1.08)
|
1.04 *
(1.02 to 1.06)
|
1.03 **
(1.01 to 1.04)
|
1.01
(0.99 to 1.02)
|
|
Length of stay
|
1.05 **
(1.03 to 1.07)
|
1.07 **
(1.04 to 1.11)
|
1.03 **
(1.02 to 1.05)
|
1.04 **
(1.03 to 1.05)
|
|
Female sex
|
0.77
(0.50 to 1.18)
|
0.93
(0.55 to 1.57)
|
0.70
(0.49 to 1.01)
|
0.71
(0.49 to 1.05)
|
|
Presence of fall history at admission
|
2.21 *
(1.36 to 3.60)
|
1.30
(0.72 to 2.36)
|
3.44 **
(2.27 to 5.22)
|
82.83 **
(42.62 to 160.98)
|
|
Number of secondary diagnoses
|
1.04
(0.91 to 1.19)
|
1.14
(0.97 to 1.34)
|
1.20 **
(1.10 to 1.32)
|
1.01
(0.92 to 1.11)
|
|
Primary medical diagnosis
|
|
|
Cancer
|
0.89
(0.52 to 1.55)
|
0.49
(0.20 to 1.20)
|
0.74
(0.43 to 1.26)
|
0.85
(0.48 to 1.49)
|
|
Respiratory or digestive disease
|
0.38 *
(0.19 to 0.75)
|
0.76
(0.36 to 1.61)
|
0.57
(0.32 to 1.02)
|
0.57
(0.31 to 1.04)
|
|
Symptom or injury
|
0.59
(0.29 to 1.19)
|
1.35
(0.64 to 2.87)
|
1.07
(0.63 to 1.81)
|
0.40 *
(0.22 to 0.73)
|
|
Cardiovascular disease
|
0.82
(0.36 to 1.86)
|
0.70
(0.23 to 2.16)
|
0.94
(0.49 to 1.83)
|
1.22
(0.67 to 2.24)
|
|
Infectious disease
|
0.39
(0.05 to 2.89)
|
1.37
(0.31 to 6.02)
|
0.92
(0.28 to 3.07)
|
0.97
(0.32 to 2.67)
|
|
Neurologic disease
|
1.33
(0.31 to 5.73)
|
4.51 *
(1.47 to 13.82)
|
2.07
(0.87 to 4.90)
|
1.49
(0.52 to 4.24)
|
|
Other†
|
1 [Reference]
|
1 [Reference]
|
1 [Reference]
|
1 [Reference]
|
|
|
|
|
|
|
|
|
|
|
|
Data are adjusted odds ratio (95% confidence interval), † Includes genitourinary, musculoskeletal, eye, ear, and skin diseases. * P < .05, ** P < .001
As for the care components of assessment, intervention group showed relatively various observations of the mobility status, mental status, and others (Figure 4-A), while the mobility assessments were dominant in the control group, whose frequency increased suddenly during the last period. Considering the interventions, universal precautions, education, and medication reviews were the most common interventions in both groups (Figure 4-B). The intervention group showed steady increase of interventions.